Advisornet Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $128K | Buy |
757
+1
| +0.1% | +$171 | 0.01% | 741 |
|
|
2025
Q4 | $128K | Buy |
756
+1
| +0.1% | +$162 | 0.01% | 730 |
|
|
2025
Q3 | $109K | Buy |
755
+616
| +443% | +$84.1K | 0.01% | 767 |
|
|
2025
Q2 | $17.6K | Buy |
139
+33
| +31% | +$4.05K | ﹤0.01% | 1318 |
|
|
2025
Q1 | $13.6K | Sell |
106
-5
| -5% | -$678 | ﹤0.01% | 1324 |
|
|
2024
Q4 | $14.7K | Sell |
111
-150
| -57% | -$21.1K | ﹤0.01% | 1219 |
|
|
2024
Q3 | $38K | Buy |
261
+26
| +11% | +$3.76K | ﹤0.01% | 995 |
|
|
2024
Q2 | $32.3K | Buy |
235
+150
| +176% | +$20K | ﹤0.01% | 957 |
|
|
2024
Q1 | $11.7K | Hold |
85
| – | – | ﹤0.01% | 1240 |
|
|
2023
Q4 | $11.5K | Sell |
85
-185
| -69% | -$22.6K | ﹤0.01% | 1267 |
|
|
2023
Q3 | $33K | Buy |
270
+15
| +6% | +$1.91K | ﹤0.01% | 893 |
|
|
2023
Q2 | $32.4K | Hold |
255
| – | – | ﹤0.01% | 941 |
|
|
2023
Q1 | $33K | Sell |
255
-122
| -32% | -$16K | ﹤0.01% | 915 |
|
|
2022
Q4 | $49.5K | Sell |
377
-718
| -66% | -$92.8K | ﹤0.01% | 793 |
|
|
2022
Q3 | $128K | Buy |
1,095
+868
| +382% | +$108K | 0.01% | 603 |
|
|
2022
Q2 | $27K | Sell |
227
-43
| -16% | -$5.1K | ﹤0.01% | 1035 |
|
|
2022
Q1 | $35K | Hold |
270
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q4 | $41K | Hold |
270
| – | – | ﹤0.01% | 1077 |
|
|
2021
Q3 | $44K | Sell |
270
-308
| -53% | -$51.8K | ﹤0.01% | 1042 |
|
|
2021
Q2 | $95K | Hold |
578
| – | – | 0.01% | 799 |
|
|
2021
Q1 | $87K | Buy |
578
+516
| +832% | +$82K | 0.01% | 792 |
|
|
2020
Q4 | $9K | Sell |
62
-298
| -83% | -$42.6K | ﹤0.01% | 1312 |
|
|
2020
Q3 | $49K | Buy |
360
+184
| +105% | +$25K | ﹤0.01% | 852 |
|
|
2020
Q2 | $24K | Buy |
176
+25
| +17% | +$3.19K | ﹤0.01% | 1057 |
|
|
2020
Q1 | $16K | Sell |
151
-202
| -57% | -$23.3K | ﹤0.01% | 1128 |
|
|
2019
Q4 | $42K | Buy |
353
+1
| +0.3% | +$112 | ﹤0.01% | 951 |
|
|
2019
Q3 | $35K | Sell |
352
-186
| -35% | -$19.5K | ﹤0.01% | 1029 |
|
|
2019
Q2 | $59K | Sell |
538
-81
| -13% | -$8.62K | 0.01% | 757 |
|
|
2019
Q1 | $69K | Buy |
619
+267
| +76% | +$29.3K | 0.01% | 651 |
|
|
2018
Q4 | $34K | Hold |
352
| – | – | ﹤0.01% | 776 |
|
|
2018
Q3 | $43K | Buy |
352
+1
| +0.3% | +$118 | 0.01% | 766 |
|
|
2018
Q2 | $39K | Sell |
351
-1,077
| -75% | -$115K | 0.01% | 775 |
|
|
2018
Q1 | $152K | Buy |
1,428
+186
| +15% | +$20.6K | 0.02% | 447 |
|
|
2017
Q4 | $133K | Buy |
+1,242
| New | +$133K | 0.02% | 423 |
|
Other funds holding IBB
CB
Advisornet Financial's IBB Position: Q1 2026 in Review
Advisornet Financial increased its iShares Biotechnology ETF (IBB) stake by 0.13% in Q1 2026, buying an estimated $171 and bringing the position to 757 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #741.
Advisornet Financial first reported a position in IBB in Q4 2017 and has held it in 34 quarters since. The position peaked at $152K in Q1 2018. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Advisornet Financial held 757 shares of iShares Biotechnology ETF worth $128K as of Q1 2026.
- Advisornet Financial bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
- iShares Biotechnology ETF made up 0.01% of Advisornet Financial's portfolio in Q1 2026, its #741 holding.
- Advisornet Financial first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 34 quarters since.
- Advisornet Financial's iShares Biotechnology ETF position peaked at $152K in Q1 2018.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.